Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellectis (CLLS) Current Assets (2016 - 2025)

Cellectis has reported Current Assets over the past 12 years, most recently at $236.2 million for Q4 2025.

  • Quarterly results put Current Assets at $236.2 million for Q4 2025, down 17.7% from a year ago — trailing twelve months through Dec 2025 was $852.8 million (up 16.85% YoY), and the annual figure for FY2025 was $236.2 million, down 17.7%.
  • Current Assets for Q4 2025 was $236.2 million at Cellectis, down from $287.1 million in the prior quarter.
  • Over the last five years, Current Assets for CLLS hit a ceiling of $287.1 million in Q4 2024 and a floor of $96.5 million in Q3 2023.
  • Median Current Assets over the past 5 years was $225.4 million (2021), compared with a mean of $187.7 million.
  • Biggest five-year swings in Current Assets: crashed 45.86% in 2022 and later soared 90.92% in 2023.
  • Cellectis' Current Assets stood at $225.4 million in 2021, then crashed by 45.86% to $122.0 million in 2022, then surged by 90.92% to $233.0 million in 2023, then grew by 23.2% to $287.1 million in 2024, then decreased by 17.7% to $236.2 million in 2025.
  • The last three reported values for Current Assets were $236.2 million (Q4 2025), $287.1 million (Q4 2024), and $233.0 million (Q4 2023) per Business Quant data.